| Dr Maureen Filippine, MD | |
|
134 South Ave, Weston, MA 02493-1923 | |
| (781) 736-0040 | |
| Not Available |
| Full Name | Dr Maureen Filippine |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 134 South Ave, Weston, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821128380 | NPI | - | NPPES |
| 205984 | Other | MA | HARVARD PILGRIM |
| 215255 | Other | MA | TUFTS |
| 3044122 | Medicaid | MA | |
| J25797 | Other | MA | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 215255 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Maureen Filippine, MD 134 South Ave, Weston, MA 02493-1923 Ph: (781) 736-0040 | Dr Maureen Filippine, MD 134 South Ave, Weston, MA 02493-1923 Ph: (781) 736-0040 |
News Archive
OncoGenex Pharmaceuticals, Inc. announced today publication of results from a randomized Phase 2 trial in the Journal of Clinical Oncology. The trial results showed a survival benefit with the investigational agent OGX-011/TV1011 (custirsen) in patients with advanced prostate cancer. The median overall survival for patients who were treated with custirsen plus first-line docetaxel/prednisone was 23.8 months compared to 16.9 months for patients treated with docetaxel/prednisone alone.
BioVex Inc, a private biotechnology company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced today that the first subject had been dosed in the Phase 1 study of its live attenuated genital herpes vaccine, ImmunoVEXHSV2. The Phase 1 study is an open label ascending dose trial, assessing safety and immune response in healthy volunteers. The study is taking place in the UK at the Chelsea and Westminster Hospital in London and will involve up to 42 already identified subjects.
Thousands of women undergo operations to get pelvic meshes inserted surgically within their lower bodies to prevent prolapsing of the abdominal organs after childbirth complications.
The Gordon Research International Conference on Magnesium was held during the second week in February in Ventura, California, to discuss the research findings on the links between deficiencies in the mineral magnesium and a host of life-threatening diseases, including heart disease and arteriosclerosis.
Bristol-Myers Squibb Company today announced results from a Phase 2 and a Phase 1b study of its investigational PD-1 immune checkpoint inhibitor nivolumab in patients with advanced or metastatic renal cell carcinoma (RCC), commonly known as kidney cancer.
› Verified 1 days ago
Dr. Robert H. Andler, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 486 Boston Post Road, Weston, MA 02693 Phone: 781-899-4456 Fax: 781-647-9578 | |
Dr. Rosemarie Dieffenbach, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 486 Boston Post Road, Weston, MA 02493 Phone: 781-899-4456 Fax: 781-647-9578 | |
Dr. Gail K Kraft, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 30 Holly Cir, Weston, MA 02493 Phone: 781-235-0560 Fax: 781-235-4345 | |
Dr. Jennifer R Kim, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 9 Riverside Rd, Health Advances, Llc, Weston, MA 02493 Phone: 781-647-3435 | |
Kristi Rae Monica, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 486 Boston Post Rd, Weston, MA 02493 Phone: 781-899-4456 | |
David L Maltz, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 215 Highland St, Weston, MA 02493 Phone: 781-943-2202 | |
Mrs. Margaret Manion, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 486 Boston Post Rd, Weston, MA 02493 Phone: 781-899-4456 Fax: 781-647-8905 |